Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

Clnical Practice Dissociated from Study Outcomes: Bad News for Our Patients?

Differences in patient characteristics, changes in treatment algorithms, and advances in device technology, together or separately, might limit the applicability of older randomized trials to contemporary clinical practice. In this case, we look at patients and devices used in the contemporary clinical practice vs. those in the EXTEND DAPT. These differences were associated with attenuated<a href="https://solaci.org/en/2022/01/25/clnical-practice-dissociated-from-study-outcomes-bad-news-for-our-patients/" title="Read more" >...</a>

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

HYDRA CE | New Models for TAVR Development

The Hydra CE has shown favorable one year efficacy for the new transcatheter aortic valve model, with large effective orifice and low transvalvular gradient associated to an acceptable complications rate.  With this study, the Hydra will obtain the CE mark and go after FDA approval (just as all new devices).  This study looked at safety<a href="https://solaci.org/en/2022/01/19/hydra-ce-new-models-for-tavr-development/" title="Read more" >...</a>

Minimizing One of Our Major Procedures to a Minimum

In some cases, full atrioventricular (AV) block occurs beyond two days after transcatheter aortic valve replacement (TAVR). This highlights the usefulness of extending monitoring after discharge, particularly in patients who tolerated the procedure well, but meet high-risk criteria. We have made great progress regarding conduction disorders in TAVR, especially after the publication of the consensus<a href="https://solaci.org/en/2022/01/13/minimizing-one-of-our-major-procedures-to-a-minimum/" title="Read more" >...</a>

The Most Relevant Articles of 2021 in Pharmacology

This last year, new data in pharmacology gave way to changes in practices and new hypotheses, when not simply further justified the already existing evidence. In this new editorial section, we share the most relevant of last year’s works to keep you up to speed on the main topics in the field. The Most Relevant<a href="https://solaci.org/en/2022/01/10/the-most-relevant-articles-of-2021-in-pharmacology/" title="Read more" >...</a>

The FDA Approves Sapien 3 with Alterra in Pulmonary Position

The US Food and Drug Administration (FDA) has cleared the SAPIEN 3 valve with the Alterra adaptive pre-stent for implantation in pulmonary position.  According to Edwards Lifesciences, this new system developed for pulmonary valve is capable of compensating a wide variety of sizes and morphologies of the right ventricular outflow tract, allowing for stable valve implantation.<a href="https://solaci.org/en/2022/01/10/the-fda-approves-sapien-3-with-alterra-in-pulmonary-position/" title="Read more" >...</a>

The Most Relevant of 2021 In Structural Heart Disease

This last year, new data in structural heart disease gave way to changes in practices and new hypotheses, when not simply further justified the already existing evidence.  In this new editorial section, we share the most relevant of last year’s works to keep you up to speed on the main topics in the field. The<a href="https://solaci.org/en/2022/01/05/the-most-relevant-of-2021-in-structural-heart-disease/" title="Read more" >...</a>

SOLACI’s Year

2021 was filled with challenges for SOLACI. Many of the initiatives we started planning in 2020 saw the light and became a reality that strengthens our society’s reach and mission.  And not just that: we have also stepped up our efforts to expand and develop our traditional institutional activities always with the intent to add<a href="https://solaci.org/en/2021/12/30/solacis-year/" title="Read more" >...</a>

The Most Read Articles of 2021: Pharmacology

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, pharmacology. Follow us to keep up to date. The Most Read Articles of 2021: Pharmacology 01- Swan Ganz Associated with Better Outcomes in Cardiogenic Shock: Is It Back? The Swan<a href="https://solaci.org/en/2021/12/24/the-most-read-articles-of-2021-pharmacology/" title="Read more" >...</a>

Lo Más Leído de 2021 - Cardiopatia estructural

The Most Read Articles of 2021: Structural Heart Disease

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, peripheral vascular disease. Follow us to keep up to date. The Most Read Articles of 2021: Structural Heart Disease 01- Surgeons’ Claim on Low-Risk Patients with Aortic Stenosis Recent<a href="https://solaci.org/en/2021/12/17/the-most-read-articles-of-2021-structural-heart-disease/" title="Read more" >...</a>

¿Cuál es el mejor tipo de dispositivo de cierre para el acceso del TAVI?

CHOICE-CLOSURE | Which Closure Device for TAVR is Better?

In patients who undergo transcatheter aortic valve replacement (TAVR) through transfemoral access, a closure device based on plug technology (MANTA VCD) is associated with a higher chance of access-related complications, but with shorter hemostasis time compared with a device with suture technology such as ProGlide VCD. Nowadays, most patients undergo TAVR through transfemoral access. Percutaneous<a href="https://solaci.org/en/2021/12/13/choice-closure-which-closure-device-for-tavr-is-better/" title="Read more" >...</a>